Insider · CIK 0001622769
Manke Isaac
Reports to the SEC for 5 companies · DORADO, PR
Transactions
27
Companies
5
Filings
12
CIK
0001622769
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-02 | ADXNAddex Therapeutics Ltd.D Disposition to Issuer | — |
| 2026-09-02 | ADXNAddex Therapeutics Ltd.A Award | — |
| 2026-09-02 | ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)D Disposition to Issuer | — |
| 2026-09-02 | ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)A Award | — |
| 2026-08-07 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-08-07 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-08-07 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2026-06-30 | QTTBQ32 Bio Inc.M Exercise/Conversion | +$150K |
| 2026-06-30 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-06-12 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-12 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-12-31 | OKUROnKure Therapeutics, Inc.A Award | — |
| 2025-10-23 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-09-30 | OKUROnKure Therapeutics, Inc.A Award | — |
| 2025-06-30 | OKUROnKure Therapeutics, Inc.A Award | — |
| 2025-05-28 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-03-31 | OKUROnKure Therapeutics, Inc.A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2025-02-24 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-01-15 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-10-04 | OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-04-01 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | +$35.3K |
| 2024-03-25 | QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Manke Isaac0001104659-26-105491SEC(opens sec.gov)
- 4Manke Isaac0001622769-26-000002SEC(opens sec.gov)
- 4/AManke Isaac0001193125-26-310969SEC(opens sec.gov)
- 4Manke Isaac0001193125-26-294694SEC(opens sec.gov)
- 4Manke Isaac0001193125-26-272698SEC(opens sec.gov)
- 4Manke Isaac0001622769-26-000001SEC(opens sec.gov)
- 4Manke Isaac0001193125-25-251993SEC(opens sec.gov)
- 4Manke Isaac0001622769-25-000003SEC(opens sec.gov)
- 4Manke Isaac0001415889-25-019052SEC(opens sec.gov)
- 4Manke Isaac0001415889-25-015018SEC(opens sec.gov)
- 4Manke Isaac0001415889-25-009659SEC(opens sec.gov)
- 4Manke Isaac0000950170-25-028306SEC(opens sec.gov)
Companies
Address
405 DORADO BEACH EAST
DORADO, PR, 00646